Hexetidine
- Not to be used by pregnant women
administration
- A01AB12 (WHO) G01AX16 (WHO)
- In general: Over-the-counter (OTC)
- 1,3-bis(2-ethylhexyl)-5-methylhexahydropyrimidin-5-amine
- 141-94-6 Y
- 3607
- DB08958 N
- 32697287 N
- 852A84Y8LS
- ChEMBL144673 N
- DTXSID1045297
- Interactive image
- CCCCC(CC)CN1CC(CN(C1)CC(CC)CCCC)(C)C
- InChI=1S/C22H46N2/c1-7-11-13-20(9-3)15-23-17-22(5,6)18-24(19-23)16-21(10-4)14-12-8-2/h20-21H,7-19H2,1-6H3 N
- Key:ZSHBZCXOMHHPCE-UHFFFAOYSA-N N
Hexetidine is an anti-bacterial and anti-fungal agent commonly used in both veterinary and human medicine. It is a local anesthetic, astringent and deodorant and has antiplaque effects.[1]
Hexetidine is the medicinal ingredient in Sterisol, which is labelled for the symptomatic treatment of: streptococcal pharyngitis ('strep throat'), tonsillitis, pharyngitis, laryngitis, gingivitis, ulcerative stomatitis, oral thrush and Vincent's angina; postoperative hygiene following tonsillectomy, throat or oral surgery. Hexetidine is not the same as Chlorhexidine, another chemical commonly used in mouthwash, or the antimicrobial drug Hexedene (C22H45N3).[2]
In the UK, hexetidine is the active ingredient in the medicated mouthwash branded Oraldene. In Canada, hexetidine was the active ingredient in the medicated mouthwash branded Steri/sol which has been discontinued. It used to be produced by McNeil Consumer Healthcare, a division of Johnson & Johnson (originally Warner–Lambert, then marketed by Pfizer after its acquisition since 2007). Oraldene contains 0.1 g/100 ml of hexetidine. In some European countries, the gargle solution and mouth spray in bottles of 40 ml named Hexoral (by Mcneil) also contains 0.2% hexetidine as its active compound. In Greece it is called Hexalen mouth wash[3] (also available in spray). Hexetidine can also be found in the mouthwash Bactidol (by Mcneil) which is sold in many Asian countries. In Germany, hexetidine vaginal suppositories branded Vagi-Hex are available to be used for vaginal antisepsis. They are also used in late pregnancy for reducing neonatal infectious mortality and morbidity due to group B streptococcal infections;[4] nonetheless, hexetidine is to be used with care during pregnancy, and its vaginal use is counter-indicated in the first three months of pregnancy.[5]
References
- ^ Kapić E, Becić F, Becić E (2002). "Hexetidine--an oral antiseptic". Med Arh. 56 (1): 43–8. PMID 11917691.
- ^ "Hexedine | CAS No- 5980-31-4 | Simson Pharma Limited".
- ^ "Γαληνός - Σκεύασμα - HEXALEN MOUTH.WASH 0,1% W/V FL x 200 ML (Γυάλινο φιαλίδιο) - Γενικά".
- ^ Weidinger H, Passloer HJ, Kovacs L, Berle B (November 1991). "[The advantage of preventive vaginal antisepsis with hexetidine in obstetrics and gynecology]". Geburtshilfe Frauenheilkd (in German). 51 (11): 929–35. doi:10.1055/s-2008-1026238. PMID 1773929.
- ^ Vagi-Hex: Gegenanzeigen (Vagi-Hex: Counterindications, in German language)
External links
- European Agency for the Evaluation of Medicinal Products overview of the medicinal properties
- v
- t
- e
- Dectaflur
- Olaflur
- Sodium fluoride
- Sodium monofluorophosphate
- Stannous fluoride
- Amphotericin B
- Benzoxonium chloride
- Chlorhexidine
- Chlortetracycline
- Clotrimazole
- Cetylpyridinium chloride
- Domiphen bromide
- Doxycycline
- Eugenol
- Hexetidine
- Hydrogen peroxide
- Mepartricin
- Metronidazole
- Miconazole
- Minocycline
- Natamycin
- Neomycin
- Oxyquinoline
- Polynoxylin
- Sodium perborate
- Tetracycline
- Tibezonium iodide
(Glucocorticoids)